Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Sources
Sources
SynBio Database
Products 101 to 110 of 117
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Sorona
by
DuPont
+
Tate & Lyle Bio Products
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
North America
+
China
+
South Korea
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Fiber
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
DWDP
(NYSE)
Value chain stage:
Input
Vaxonella
by
Prokarium
Biotech components:
Bacteria
Business models:
B2C
Country of production:
UK
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2019/05/15 16:12 (5 years ago)
Known funding amount:
12,600,000 USD
Funding types:
Venture Capital
Industry:
Health
Market status:
On the market
+
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
Stevia
by
Evolva
Biotech components:
Enzyme
Business models:
B2B
Country of production:
USA
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
86,000,000 CHF
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Additive
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
EVE
(SWX)
Value chain stage:
Finished Product
Succinic Acid
by
Myriant
+
Royal DSM
+
BioAmber, Inc.
Biotech components:
Molecule
Business models:
B2C
Country of production:
USA
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/11/08 14:37 (5 years ago)
Known funding amount:
155,600,000 USD
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
+
Health
+
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Additive
+
Chemical
+
Personal Care (Topical)
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BIOA
(NYSE)
Value chain stage:
Input
Sun-Driven Microbial Synthesis of Chemicals in Space
by
Oakbio
+
Wyss Institute
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
37,000,000 USD
Funding types:
University
+
Government
Industry:
Food & Agriculture
Market status:
Early Stage Concept
Organization type(s):
Private Company
Product categories:
Plant
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
Susterra
by
DuPont
+
Tate & Lyle Bio Products
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Fiber
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
DWDP
(NYSE)
Value chain stage:
Input
SYN-004 (RIBAXAMASE)
by
Synthetic Biologics
Biotech components:
Microbe
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
12,467,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
SYN
(NYSEMKT)
Value chain stage:
Finished Product
Synbio Lantibiotics
by
University of Groningen
Biotech components:
Bacteria
Business models:
B2B
Country of production:
USA
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
N/A
Funding types:
Public Funding
Industry:
Health
Market status:
More information needed
+
Under Development
Organization type(s):
University
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
Synthorin™ Protein
by
Synthorx
+
Scripps Research Institute
Biotech components:
Molecule
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Research
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
79,000,000 USD
Funding types:
Venture Capital
Industry:
Health
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Open Release
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
TransFerm® Yield+
by
Mascoma
Biotech components:
Microbe
+
Fungus
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
+
Europe
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
179,800,000 USD
Funding types:
Venture Capital
Industry:
Industrial
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Fuel and Energy
+
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
1
…
3
4
5
6
7
8
9
10
11
12
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
